This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
LANXESS AG recently announced that Matthias Zachert, currently chief financial officer (CFO) of Merck KGaA in Darmstadt, Germany, will take over as chairman of the Board of Management on April 1. He will take over for CFO Bernhard Duettmann, who is currently serving as chairman of the Board of Management.
LANXESS is a leading specialty chemicals company offering polymer additives, urethane systems, biocides, and intermediates. Our application experts and innovative chemistries enhance performance, preservation, HS&E, ease of use, and manufacturing/economy. In 2021, LANXESS completed the acquisition of Emerald Kalama and expanded its portfolio of plasticizers, modifiers, and benzoates.
A leading global specialty chemicals company. Core business is the development, manufacturing, and marketing of chemical intermediates, additives, specialty chemicals, and plastics.
Report Abusive Comment